Cadre Holdings, Inc. (CDRE) Operating Margin
- Operating margin · 12 months: Value 10.07%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 10.07% | Operating income / revenue. Period ending 2026-06-30. $69.07M ÷ $685.65M × 100 ≈ 10.07% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 69.07M USD | Operating Income (Loss) |
| Revenue | 685.65M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 399.10M USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 208.30M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69.07M | $685.65M | $399.10M | (m) | $208.30M | 10.07% |
| 2026-03-31 | $61.29M | $635.63M | $371.97M | (m) | $190.21M | 9.64% |
| 2025-12-31 | $67.35M | $610.31M | $350.68M | $11.40M | $183.13M | 11.04% |
| 2025-09-30 | $76.31M | $619.07M | $354.88M | (m) | $177.56M | 12.33% |
| 2025-06-30 | $63.07M | $572.61M | $335.02M | (m) | $165.91M | 11.01% |
| 2025-03-31 | $68.33M | $559.81M | $327.82M | (m) | $159.36M | 12.21% |
| 2024-12-31 | $66.76M | $567.56M | $334.08M | $8.38M | $158.32M | 11.76% |
| 2024-09-30 | $50.03M | $516.16M | $310.11M | (m) | $148.18M | 9.69% |
| 2024-06-30 | $61.34M | $531.87M | $312.23M | (m) | $150.51M | 11.53% |
| 2024-03-31 | $57.28M | $508.64M | $296.91M | (m) | $145.99M | 11.26% |
| 2023-12-31 | $56.52M | $482.53M | $281.81M | $6.95M | $140.52M | 11.71% |
| 2023-09-30 | $56.56M | $481.59M | $282.10M | (m) | $140.47M | 11.75% |
| 2023-06-30 | $50.15M | $468.03M | $278.40M | (m) | $135.89M | 10.71% |
| 2023-03-31 | $42.42M | $465.18M | $283.07M | (m) | $134.59M | 9.12% |
| 2022-12-31 | $16.72M | $457.84M | $282.16M | $7.09M | $153.29M | 3.65% |
| 2022-09-30 | $13.31M | $437.73M | $271.38M | (m) | $146.22M | 3.04% |
| 2022-06-30 | $14.54M | $424.83M | $262.92M | (m) | $142.17M | 3.42% |
| 2022-03-31 | $21.80M | $421.16M | $254.24M | (m) | $140.86M | 5.18% |
| 2021-12-31 | $51.72M | $427.29M | $256.60M | $6.46M | $114.96M | 12.10% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $49.80M | $404.64M | $251.70M | $5.63M | $106.63M | 12.31% |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |